Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifidobacterium lactis XLTG11 for functional constipation in infants
ChiCTR2100053695Phase 4Recruiting
- Sponsor
- Chengdu Women's and Children's Central Hospital
- Start
- Nov 2021
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of bifidobacterium animalis subsp. lactis XLTG11 in functional constipation (FC) (2 arms), sponsored by Chengdu Women's and Children's Central Hospital. Primary endpoints: Defecation frequency, Fecal character and 1 more. Started Nov 2021; status: recruiting.
02
Drugs
bifidobacterium animalis subsp. lactis XLTG11
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on ChiCTR2100053695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053695.